Quick Answer
Twist Bioscience Corp reported Long Term Debt of $1.40 million for the year ending 2020.
- Twist Bioscience Corp showed a decrease of -68.1% in Long Term Debt from 2019 to 2020.
- This data is from Twist Bioscience Corp's annual report (Form 10-K), filed with the SEC on November 23, 2021.
- XBRL data for this metric is available from 2018 to 2020 (3 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q4 2018: $6.53 million | Q1 2019: $5.83 million | Q2 2019: $5.12 million | Q4 2019: $3.67 million | Q1 2020: $2.93 million | Q2 2020: $2.17 million | Q4 2020: $625.0 thousand.
- Over the full 3 years of available data (2018 to 2020), Twist Bioscience Corp's Long Term Debt has declined by 80.6%.
- Historical annual values: Fiscal year 2020: $1.40 million | Fiscal year 2019: $4.40 million | Fiscal year 2018: $7.22 million.
- Data sourced from SEC EDGAR public filings as of August 8, 2026.
Last verified: